PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
21858227-6	2011	In control mice the retinoid (but not TPA) induced parakeratosis and diminished expression of keratin 10 and loricrin, markers of early and terminal epidermal differentiation, respectively.	Retinoids	20-28	keratin 10	Mus musculus	94-104
22490914-18	2012	Cytokeratin 10 was almost negatively expressed in Pranoprofen or Fluorometholone treated groups, and remained positive in the corneal epithelium with other treatments.	pyranoprofen	50-61	keratin 10	Mus musculus	0-14
22490914-18	2012	Cytokeratin 10 was almost negatively expressed in Pranoprofen or Fluorometholone treated groups, and remained positive in the corneal epithelium with other treatments.	Fluorometholone	65-80	keratin 10	Mus musculus	0-14
17727842-7	2008	Retinoid topical treatments reduced p27 and CYP26A1 mRNA levels in TG(+) and TG(-) mouse skin in K14 and K10/FLAG-CRABPI transgenic mice.	Retinoids	0-8	keratin 10	Mus musculus	105-108
18276784-3	2008	When such adult mice were exposed to Dox, they exhibited epithelial hyperplasia with increases in phospho-extracellular signal-regulated kinase 1/2-, nuclear beta-catenin-, and 5-bromo-2"-deoxyuridine-labeled cells and altered keratin (K) 14 (K14) expression pattern, a normal K12 expression pattern, and the normal absence of K10.	Doxycycline	37-40	keratin 10	Mus musculus	327-330
15679119-3	2004	Sebaceous gland cells of K10-/- mice showed an accelerated turnover and secreted more sebum including wax esters, triglycerides, and cholesterol esters.	wax esters	102-112	keratin 10	Mus musculus	25-28
15385531-6	2004	We identified cytokeratin 10 (K10) as the ligand recognized by ClfB.	clfb	63-67	keratin 10	Mus musculus	30-33
15385531-7	2004	Here we have shown that purified recombinant human and murine K10 immobilized on a plastic surface supports adherence of S. aureus in a ClfB-dependent manner.	clfb	136-140	keratin 10	Mus musculus	62-65
15385531-13	2004	The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)n. A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB+ to immobilized MK10 to a level of 80%, whereas control peptides had no effect.	Tyrosine	63-66	keratin 10	Mus musculus	19-22
15385531-13	2004	The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)n. A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB+ to immobilized MK10 to a level of 80%, whereas control peptides had no effect.	Glycine	68-71	keratin 10	Mus musculus	19-22
15385531-13	2004	The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)n. A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB+ to immobilized MK10 to a level of 80%, whereas control peptides had no effect.	Serine	72-75	keratin 10	Mus musculus	19-22
15385531-13	2004	The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)n. A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB+ to immobilized MK10 to a level of 80%, whereas control peptides had no effect.	Glycine	126-133	keratin 10	Mus musculus	19-22
15385531-13	2004	The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)n. A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB+ to immobilized MK10 to a level of 80%, whereas control peptides had no effect.	clfb	211-215	keratin 10	Mus musculus	19-22
15385531-13	2004	The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)n. A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB+ to immobilized MK10 to a level of 80%, whereas control peptides had no effect.	Menaquinone 10	232-236	keratin 10	Mus musculus	19-22
17727842-6	2008	ATRA treatment (10 microM) resulted in a 59.9+/-9.8% increase (p<0.05) in the BrdU labeling index in K10/FLAG-CRABPI TG(+) mice vs. TG(-) mice.	Tretinoin	0-4	keratin 10	Mus musculus	104-107
17637822-4	2008	In acitretin-treated RHE cultures, there was a reduction in keratohyalin granules and filaggrin expression in the stratum granulosum, a loss of keratin 10 expression in the stratum spinosum, and an increase in keratin 19 expression in all viable cell layers.	Acitretin	3-12	keratin 10	Mus musculus	144-154
17459086-3	2007	Eight-to 9-week-old mice treated for 3 weeks with subcutaneous implants of 0.2-200 mg BPA pellets induced the expression of cytokeratin 10 (CK10) in prostatic basal epithelial cells in a dose-dependent manner.	bisphenol A	86-89	keratin 10	Mus musculus	124-138
17459086-3	2007	Eight-to 9-week-old mice treated for 3 weeks with subcutaneous implants of 0.2-200 mg BPA pellets induced the expression of cytokeratin 10 (CK10) in prostatic basal epithelial cells in a dose-dependent manner.	bisphenol A	86-89	keratin 10	Mus musculus	140-144
17459086-5	2007	Fetal exposure to low-dose BPA (20 microg/kg/day) from gestation day (GD) 13 to GD18 induced permanent CK10 expression in basal cells of the adult prostate similar to DES (0.2 microg/kg/day).	bisphenol A	27-30	keratin 10	Mus musculus	103-107
17459086-6	2007	These results indicate that in mouse, BPA can directly elicit CK10 expression in prostatic epithelium, and that this change can be elicited by doses as low as 20 microg/kg/day.	bisphenol A	38-41	keratin 10	Mus musculus	62-66
15679119-3	2004	Sebaceous gland cells of K10-/- mice showed an accelerated turnover and secreted more sebum including wax esters, triglycerides, and cholesterol esters.	Triglycerides	114-127	keratin 10	Mus musculus	25-28
15679119-3	2004	Sebaceous gland cells of K10-/- mice showed an accelerated turnover and secreted more sebum including wax esters, triglycerides, and cholesterol esters.	Cholesterol Esters	133-151	keratin 10	Mus musculus	25-28
10469329-6	1999	Most importantly, the analysis of ceramide subpopulations revealed that the total amount of ceramide 2 was elevated in keratin 10-deficient mice, whereas ceramides 1, 3, 4, and 5 were decreased among total stratum corneum lipids.	Ceramides	92-100	keratin 10	Mus musculus	119-129
15482487-4	2004	Here, we report that K10(-/-) mice treated with 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) developed far less papillomas than wild-type mice.	9,10-Dimethyl-1,2-benzanthracene	48-78	keratin 10	Mus musculus	21-24
15482487-4	2004	Here, we report that K10(-/-) mice treated with 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) developed far less papillomas than wild-type mice.	9,10-Dimethyl-1,2-benzanthracene	80-84	keratin 10	Mus musculus	21-24
15482487-4	2004	Here, we report that K10(-/-) mice treated with 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) developed far less papillomas than wild-type mice.	Tetradecanoylphorbol Acetate	86-122	keratin 10	Mus musculus	21-24
15482487-4	2004	Here, we report that K10(-/-) mice treated with 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) developed far less papillomas than wild-type mice.	Tetradecanoylphorbol Acetate	124-127	keratin 10	Mus musculus	21-24
15482487-5	2004	BrdU(5-bromo-2"-deoxyuridine)-labeling revealed a strongly accelerated keratinocyte turnover in K10(-/-) epidermis suggesting an increased elimination of initiated keratinocytes at early stages of developing tumors.	Bromodeoxyuridine	0-4	keratin 10	Mus musculus	96-99
15482487-5	2004	BrdU(5-bromo-2"-deoxyuridine)-labeling revealed a strongly accelerated keratinocyte turnover in K10(-/-) epidermis suggesting an increased elimination of initiated keratinocytes at early stages of developing tumors.	Bromodeoxyuridine	5-28	keratin 10	Mus musculus	96-99
11889133-6	2002	This process requires a functional retinoblastoma (pRb) gene product and is mediated by K10-induced inhibition of Akt and PKCzeta, two signaling intermediates belonging to the phosphoinositide (PI) 3-kinase signal transduction pathway (Paramio, J. M., Segrelles, C., Ruiz, S., and Jorcano, J. L. (2001) Mol.	Phosphatidylinositols	176-192	keratin 10	Mus musculus	88-91
11150243-6	2001	This response to DES involved multilayering of basal epithelial cells, expression of cytokeratin 10, and up-regulation of the progesterone receptor.	Diethylstilbestrol	17-20	keratin 10	Mus musculus	85-99
9019167-4	1995	CS stimulated cornification and blocked the induction of K10 in keratinocytes induced to differentiate by calcium.	cholesteryl sulfate	0-2	keratin 10	Mus musculus	57-60
9019167-4	1995	CS stimulated cornification and blocked the induction of K10 in keratinocytes induced to differentiate by calcium.	Calcium	106-113	keratin 10	Mus musculus	57-60
7896886-4	1995	BAPTA also inhibited the expression of K1, K10 and loricrin mRNA.	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid	0-5	keratin 10	Mus musculus	43-46
34515797-6	2021	Seven days of dermal exposure to triclosan decreased filaggrin 2 and keratin 10 expression, but increased filaggrin and keratin 14 protein along with the danger signal S100a8 and interleukin-4.	Triclosan	33-42	keratin 10	Mus musculus	69-79
2426152-1	1986	When mouse-teratocarcinoma-derived fibroblasts (1246 cell line) are subjected to treatment with the inhibitor of DNA methylation, 5-Azacytidine (5 AzaC), they transiently express at 55-kilodalton intermediate-filament protein recognized by the epithelial-specific monoclonal antibody, TROMA-1, although they retain a fibroblastic morphology.	Azacitidine	130-143	keratin 10	Mus musculus	196-225
2426152-1	1986	When mouse-teratocarcinoma-derived fibroblasts (1246 cell line) are subjected to treatment with the inhibitor of DNA methylation, 5-Azacytidine (5 AzaC), they transiently express at 55-kilodalton intermediate-filament protein recognized by the epithelial-specific monoclonal antibody, TROMA-1, although they retain a fibroblastic morphology.	3,5-di-t-butyl-4-methylphenyl N-methylcarbamate	147-151	keratin 10	Mus musculus	196-225
32232349-8	2020	In the BAC+Feno group, the expression of K10 and Ki67 was lower than in the other three groups.	flubendiamide	11-15	keratin 10	Mus musculus	41-44
33105942-33	2020	(5) The number of keratin 10 positive cells in the epidermis tissue of wound margin of mice in PBS group was significantly higher than that in WT control group, DETC group, and IGF-I group (t=11.59, 9.51, 3.48, P<0.05 or P<0.01).	pbs	95-98	keratin 10	Mus musculus	18-28
33105942-35	2020	The percentage of keratin 10 positive cells on CD 10 in DETC co-culture group was (55.7+-0.7)%, significantly lower than (67.1+-1.2)% in control group (t=8.34, P<0.01).	DETC	56-60	keratin 10	Mus musculus	18-28
32168425-6	2020	Moreover, Tp63 bound to KRT10 promoter region to activate its transcription in basal keratinocytes; the promotive effects of ozone on Tp63 and KRT10 were significantly reversed by Tp63 silence.	Ozone	125-130	keratin 10	Mus musculus	24-29
32168425-6	2020	Moreover, Tp63 bound to KRT10 promoter region to activate its transcription in basal keratinocytes; the promotive effects of ozone on Tp63 and KRT10 were significantly reversed by Tp63 silence.	Ozone	125-130	keratin 10	Mus musculus	143-148
32168425-8	2020	In conclusion, the application of ozonated oil could be an efficient and safe treatment for psoriasis; ozone promotes the differentiation of keratinocytes via increasing Tp63-mediated transcription of KRT10, therefore improving psoriasis.	ozonated	34-42	keratin 10	Mus musculus	201-206
32168425-8	2020	In conclusion, the application of ozonated oil could be an efficient and safe treatment for psoriasis; ozone promotes the differentiation of keratinocytes via increasing Tp63-mediated transcription of KRT10, therefore improving psoriasis.	Oils	43-46	keratin 10	Mus musculus	201-206
25127551-6	2014	After 96 h, SM was found to induce skin injury characterized by edema, epidermal hyperplasia, loss of the differentiation marker, keratin 10 (K10), upregulation of the skin wound marker keratin 6 (K6), disruption of the basement membrane anchoring protein laminin 322, and increased expression of epidermal COX2.	Samarium	12-14	keratin 10	Mus musculus	130-140
29286080-6	2018	Treatment with erlotinib significantly increased the corneal epithelial cell apoptosis, and led to a significantly increased number of epithelial cell layers and increased keratin 10 expression.	Erlotinib Hydrochloride	15-24	keratin 10	Mus musculus	172-182
28000052-9	2017	Further in-depth analysis showed that CK10 exacerbated acute lung injury-associated responses, including inflammatory response, cell death, reactive oxygen species production and complement response.	Reactive Oxygen Species	140-163	keratin 10	Mus musculus	38-42
25533330-7	2015	Delphinidin treatment also increased the expression and processing of caspase-14, and expression of filaggrin, loricrin, keratin-1 and keratin-10.	delphinidin	0-11	keratin 10	Mus musculus	135-145
25127551-6	2014	After 96 h, SM was found to induce skin injury characterized by edema, epidermal hyperplasia, loss of the differentiation marker, keratin 10 (K10), upregulation of the skin wound marker keratin 6 (K6), disruption of the basement membrane anchoring protein laminin 322, and increased expression of epidermal COX2.	Samarium	12-14	keratin 10	Mus musculus	142-145
23255810-8	2013	These results demonstrated that the PA gene mainly determines the pathogenicity discrepancy between CK10 and GS10 in mice.	Protactinium	36-38	keratin 10	Mus musculus	100-104
23255810-9	2013	We further determined that arginine (R) at position 353 of the PA gene contributes to the high virulence of CK10 in mice.	Arginine	27-35	keratin 10	Mus musculus	108-112
23255810-9	2013	We further determined that arginine (R) at position 353 of the PA gene contributes to the high virulence of CK10 in mice.	Arginine	37-38	keratin 10	Mus musculus	108-112
23255810-9	2013	We further determined that arginine (R) at position 353 of the PA gene contributes to the high virulence of CK10 in mice.	Protactinium	63-65	keratin 10	Mus musculus	108-112
23255810-10	2013	The reciprocal substitution at position 353 in PA or the exchange of the entire PA gene largely caused the transfer of viral phenotypes, including virus replication, polymerase activity, and manipulation of the innate response, between CK10 and GS10.	Protactinium	47-49	keratin 10	Mus musculus	236-240
23255810-10	2013	The reciprocal substitution at position 353 in PA or the exchange of the entire PA gene largely caused the transfer of viral phenotypes, including virus replication, polymerase activity, and manipulation of the innate response, between CK10 and GS10.	Protactinium	80-82	keratin 10	Mus musculus	236-240